Streetbeat News

Analyst Ratings

WGS

GeneDx Holdings (NASDAQ:WGS) has received mixed analyst ratings, with a recent increase in average price targets. Analysts have raised their price targets, reflecting a more optimistic outlook. The company has shown strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:01 pm

LMT

High-rolling investors have shown bearish sentiment on Lockheed Martin (NYSE:LMT) through options trading, with 50% of trades being bearish. The stock is currently trading at $611.35, with a consensus target price of $656.25. Analysts maintain positive ratings, but unusual options activity suggests potential market movements.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:01 pm

PGY

Pagaya Techs (NASDAQ:PGY) has been analyzed by 9 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $25.22, a decrease from the previous $30.86. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Pagaya Techs is a financial technology company with significant revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:00 pm

KGS

RBC Capital analyst Elvira Scotto has maintained an Outperform rating on Kodiak Gas Services (NYSE:KGS) and raised the price target from $31 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 5:00 pm

OC

In the last three months, analysts have shown varied sentiments towards Owens-Corning (NYSE:OC), with recent ratings indicating a positive shift in price targets. The average 12-month price target has increased by 1.93% to $189.8. Analysts have adjusted their ratings and price targets, reflecting their response to market conditions and company performance. Despite revenue growth, Owens-Corning faces challenges with profitability, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:00 pm

NVCR

NovoCure (NASDAQ:NVCR) has received mixed analyst ratings over the past three months, with a recent average price target of $28.0. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance. NovoCure has shown strong revenue growth but faces challenges with profitability and asset returns.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:00 pm

TVTX

Travere Therapeutics (NASDAQ:TVTX) has received diverse analyst ratings, with a majority being bullish. The average 12-month price target has increased by 18.57% to $21.96. The company shows strong revenue growth but faces challenges in debt management and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:00 pm

KNTK

RBC Capital analyst Elvira Scotto maintains an Outperform rating on Kinetik Holdings (NYSE:KNTK) and raises the price target from $46 to $52.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 4:58 pm

KMI

RBC Capital analyst Elvira Scotto maintains a Sector Perform rating on Kinder Morgan (NYSE:KMI) and raises the price target from $22 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 4:57 pm

GEL

RBC Capital analyst Elvira Scotto maintains an Outperform rating on Genesis Energy (NYSE:GEL) and raises the price target from $15 to $16.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 4:55 pm